Retroperitoneal Fibrosis in a Patient with Parkinsonʼs Disease Treated with Pergolide

Authors:
  • JLJoaqín López-Alvarez
    Joaqín López-Alvarez
  • MSManuel Sánchez-Chapado
    Manuel Sánchez-Chapado
  • EMEduardo Montero
    Eduardo Montero
  • JMJoaquín Miquel
    Joaquín Miquel
  • ASAdela Sierra
    Adela Sierra
  • FGFernando Gutiérrez
    Fernando Gutiérrez
Publisher website
Google Scholar
Abstract
We describe a 68-year-old patient with Parkinson's disease who developed retroperitoneal fibrosis during pergolide treatment. Because pergolide is an ergot derivative, it could be related to the development of this complication.